InvestorsHub Logo
Followers 30
Posts 1475
Boards Moderated 0
Alias Born 07/10/2013

Re: changes_iv post# 43315

Wednesday, 11/17/2021 7:17:14 AM

Wednesday, November 17, 2021 7:17:14 AM

Post# of 44690
FDA is waiting on data for Zyesami IV. The Zyesami inhaled form would be used to pursue about (5) other lung indications, among them ARDS and COPD.